WuXi NextCODE strikes deal to sequence and share 1,000 cancer genomes

WuXi NextCODE has struck another sequencing agreement. The latest deal will see the service provider sequence samples taken from 1,000 cancer patients in San Antonio, TX. Phase I clinical trial specialist South Texas Accelerated Research Therapeutics plans to link the genome data to patient records using Medidata ($MDSO) Rave, before making the resource available to researchers and clinicians. Release | Article

Suggested Articles

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.